Frontiers in Medicine (Jan 2023)
Corrigendum: JAK1/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis
- Zhanying Hou,
- Zhanying Hou,
- Xuehan Su,
- Xuehan Su,
- Guangming Han,
- Ruzeng Xue,
- Yangxia Chen,
- Ye Chen,
- Huan Wang,
- Bin Yang,
- Yunsheng Liang,
- Suyun Ji
Affiliations
- Zhanying Hou
- Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China
- Zhanying Hou
- Department of Dermatology, Shenzhen Longhua District Central Hospital, Shenzhen, China
- Xuehan Su
- The First School of Clinical Medicine, Southern Medical University, Guangzhou, China
- Xuehan Su
- Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China
- Guangming Han
- Department of Rheumatology, Dermatology Hospital, Southern Medical University, Guangzhou, China
- Ruzeng Xue
- Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China
- Yangxia Chen
- Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China
- Ye Chen
- Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China
- Huan Wang
- Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China
- Bin Yang
- Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China
- Yunsheng Liang
- Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China
- Suyun Ji
- Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China
- DOI
- https://doi.org/10.3389/fmed.2022.1125836
- Journal volume & issue
-
Vol. 9
Abstract
No abstracts available.Keywords
